Glyburide
- Product NDC
- 0115-1743
- 11-digit product format
- 001151743
- Labeler code
- 0115
- Product ID
- 0115-1743_60f84d8c-eabb-40f0-aa63-56c62c46fe43
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Glyburide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Application
- ANDA206079
- Marketing category
- ANDA
- Marketing start
- 2016-06-01
- Marketing end
- 0000-00-00
- Substance
- GLYBURIDE
- Active strength
- 3 mg/1
- Pharmacologic classes
- Sulfonylurea [EPC],Sulfonylurea Compounds [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0115-1743-01 | Glyburide | 100 in 1 BOTTLE | TABLET | 100 | | 4 |
| 0115-1743-03 | Glyburide | 1000 in 1 BOTTLE | TABLET | 1000 | | 4 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0115-1743 | GLYBURIDE TABLET [AMNEAL PHARMACEUTICALS OF NEW YORK LLC] | 4 | Legacy NDC, 2 package rows | 20201230_5c391b11-68e9-4040-8408-56b43ee853f5.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0115-1743-01 | 00115174301 | 100 TABLET in 1 BOTTLE (0115-1743-01) | 100 tablet | 2016-06-01 | 0000-00-00 | No | No | Current |
| 0115-1743-03 | 00115174303 | 1000 TABLET in 1 BOTTLE (0115-1743-03) | 1000 tablet | 2016-06-01 | 0000-00-00 | No | No | Current |